Table 2.
Variable | All patients (n = 465) | Antimigraine drug users (n = 365) | No antimigraine drug users (n = 100) | p value |
---|---|---|---|---|
Age (years), mean (SD) | 43.5 (10.9) | 43.8 (10.9) | 42.3 (11.0) | 0.210 |
Gender female, n (%) | 433 (93.1) | 338 (92.6) | 95 (95.0) | 0.402 |
CGI, mean (SD) | 2.4 (2.3) | 2.4 (2.3) | 2.7 (2.2) | 0.150 |
RI, mean (SD) | 17.6 (10.5) | 17.7 (10.3) | 17.5 (11.3) | 0.861 |
Depression, n (%) | 307 (66.0) | 240 (65.8) | 67 (67.0) | 0.816 |
Diagnosis of migraine, n (%) | 233 (50.1) | 133 (36.4) | 100 (100)a | <0.001 |
CGI care gap index, RI risk index, SD standard deviation
aPatients who neither used antimigraine drugs nor had migraine diagnosis were not included in the study